We are developing the next generation of acute infection therapeutics. These will be first-in-class broad spectrum non-antibiotic therapeutics. Our drug drug targets are derived from strong clinical data and are delivered using clinically validated lipid nanoparticle RNA systems to well established target cell types.
Our target indications include pneumonia, sepsis, and other conditions where endotoxin enters the blood and causes uncontrolled inflammation.
Company Details
- Address
- 2665 East Mall, Vancouver,bc,canada
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- https://resolventx.com/
- Keywords
- PRECISION NANOSYSTEMS US.
- HQ
- Vancouver, BC
Resolve Nanotherapeutics Corp. Questions
Resolve Nanotherapeutics Corp.'s website is https://resolventx.com/
Resolve Nanotherapeutics Corp.'s LinkedIn profile is https://ca.linkedin.com/company/resolve-nanotherapeutics-corp
Resolve Nanotherapeutics Corp.'s industry is
Nanotechnology Research
Resolve Nanotherapeutics Corp.'s top competitors are
Tydra Labs,
Innovation Ubc,
Autochart,
Incisive Genetics,
Leap,
Cerecura Nanotherapeutics,
Thera-T Pharmaceutics, Llc,
Canadian Poultry Research Network,
Nanovation Therapeutics™,
Precision Nanosystems Us, Inc..
Resolve Nanotherapeutics Corp.'s categories are Nanotechnology Research
